Author:
Gao Shixi,Peng Junxiang,Rong Mei,Liu Yang,Xu Yanhong,Wei Jianhe
Abstract
AbstractDragon's blood, the red resin derived from the wounded Dracaena, is a precious traditional medicine used by different culture. Dracaena cochinchinensis is one of the main species of Dracaena, and is the endangered medicinal plants in China. The vulnerable status severely limits the medicinal value and wide application of dragon’s blood. Therefore, it’s essential to analyze the mechanisms that form dragon’s blood in order to increase artificial production. To clarify the mechanisms forming dragon’s blood, understanding gene expression in the flavonoid biosynthesis pathway is the foundation. However, reference genes of D. cochinchinensis haven’t been analyzed. In this study, expression profiles of seven commonly used housekeeping genes (Actin, α-EF, UBC, β-tubulin, 18S, GAPDH, His) were evaluated by using quantitative real-time PCR combined with the algorithms geNorm, NormFinder, BestKeeper, and RefFinder. On the basis of overall stability ranking, the best reference genes were the combinations β-tubulin +UBC for wounded stems and α-EF +18S + Actin for different organs. Reliability of the recommended reference genes was validated by normalizing relative expression of two key enzyme genes PAL1 and CHI1 in the flavonoid biosynthesis pathway. The results provide a foundation to study gene expression in future research on D. cochinchinensis or other Dracaena.
Funder
the National Natural Science Foundation of China
the Natural Science Foundation of Beijing
the CAMS Innovation Fund for Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Li, N., Ma, Z., Li, M., Xing, Y. & Hou, Y. Natural potential therapeutic agents of neurodegene-rative diseases from the traditional herbal medicine Chinese dragon’s blood. J. Ethnopharmacol. 152, 508–521 (2014).
2. Meng, X. X. et al. Study on the antibacterial effect of dragon’s blood and spider incense in vitro. West China J. Pharm. Sci. 32, 109–110 (2017).
3. Wang, H. et al. Flavonoids from artificially induced dragon’s blood of Dracaena cambodiana. Fitoterapia. 121, 1–5 (2017).
4. Wen, F., Zhao, X., Zhao, Y., Lu, Z. & Guo, Q. The anticancer effects of Resina Draconis extract on cholangiocarcinoma. Tumour. Biol. 37, 15203 (2016).
5. Zhang, L. et al. Advance of the chemical components and pharmacological effects of Draconis Sanguis and Resina Draconis. Chin. J. Mod. Appl. Pharm. 36, 2605–2611 (2019).